Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gyldmark

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|September 30, 1996
[Cost-analyses of intensive care units]M Gyldmark
Critical Care Medicine|May 1, 1995
A review of cost studies of intensive care units: problems with the cost conceptM Gyldmark
Health Policy (Amsterdam, Netherlands)|March 9, 1993
The treatment and care costs of people with HIV infection or AIDS: development of a standardised cost framework for EuropeK Tolley, M Gyldmark
Health Policy (Amsterdam, Netherlands)|June 6, 1998
Economic evaluation of programmes aiming at eradicating infectious diseasesM Gyldmark, A Alban
Social Science & Medicine (1982)|September 15, 2001
Demand for health care in Denmark: results of a national sample survey using contingent valuationM Gyldmark, G C Morrison
Health Economics|December 1, 1992
Appraising the use of contingent valuationG C Morrison, M Gyldmark
Pharmacoeconomics|November 3, 1997
The Danish approach to standards for economic evaluation methodologiesA Alban, M Gyldmark, A V Pedersen, et al.
The Journal of International Medical Research|March 18, 2010
Cost-effectiveness of erlotinib versus docetaxel for second-line treatment of advanced non-small-cell lung cancer in the United KingdomG Lewis, M Peake, R Aultman, et al.
AIDS (London, England)|April 1, 1993
Economic impact of the AIDS epidemic in the European Community: towards multinational scenarios on hospital care and costsM J Postma, R Leidl, A M Downs, et al.
Vaccine|September 25, 2003
The cost of measles in industrialised countriesH Carabin, W J Edmunds, M Gyldmark, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|September 30, 1996
[Cost-analyses of intensive care units]M Gyldmark
Critical Care Medicine|May 1, 1995
A review of cost studies of intensive care units: problems with the cost conceptM Gyldmark
Health Policy (Amsterdam, Netherlands)|March 9, 1993
The treatment and care costs of people with HIV infection or AIDS: development of a standardised cost framework for EuropeK Tolley, M Gyldmark
Health Policy (Amsterdam, Netherlands)|June 6, 1998
Economic evaluation of programmes aiming at eradicating infectious diseasesM Gyldmark, A Alban
Social Science & Medicine (1982)|September 15, 2001
Demand for health care in Denmark: results of a national sample survey using contingent valuationM Gyldmark, G C Morrison
Health Economics|December 1, 1992
Appraising the use of contingent valuationG C Morrison, M Gyldmark
Pharmacoeconomics|November 3, 1997
The Danish approach to standards for economic evaluation methodologiesA Alban, M Gyldmark, A V Pedersen, et al.
The Journal of International Medical Research|March 18, 2010
Cost-effectiveness of erlotinib versus docetaxel for second-line treatment of advanced non-small-cell lung cancer in the United KingdomG Lewis, M Peake, R Aultman, et al.
AIDS (London, England)|April 1, 1993
Economic impact of the AIDS epidemic in the European Community: towards multinational scenarios on hospital care and costsM J Postma, R Leidl, A M Downs, et al.
Vaccine|September 25, 2003
The cost of measles in industrialised countriesH Carabin, W J Edmunds, M Gyldmark, et al.
Pageof 2